Literature DB >> 15808539

The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation.

A Yoshizawa1, A Ito, Y Li, T Koshiba, S Sakaguchi, K J Wood, K Tanaka.   

Abstract

UNLABELLED: Recent evidence suggests that CD4+CD25+ regulatory T cells (Tregs) affect immune responses, including those to alloantigens in organ transplants. We have followed a group of liver allograft recipients with good liver graft function who have been weaned off immunosuppression (IS). The purpose of this study was to determine whether Tregs contributed functionally to the mechanisms of graft acceptance.
MATERIAL AND METHODS: The functional assay used peripheral blood obtained from LTx recipients free of immunosuppression. The Whole population of CD4+ T cells and the CD4+ T cells depleted of CD4+CD25 high cells were tested for proliferation against donor versus third party stimulators. Moreover to determine the antigen-specificity of the Tregs, serially diluted numbering of CD4+CD25+ T cells were co-cultured with CD4+CD25- T cells. The proliferation responses were examined toward donor versus third party stimulators. RESULT: CD4+ T cells from all LTx recipients off immunosuppression showed hyporesponsiveness to the donor but not to third party stimulators. However, even after depletion of the CD4+CD25 high population, the cells continued to be hyporesponsive toward the donor. In four out of five cases, the suppression exhibited by CD4+CD25+ T cells was more specific for the donor. DISCUSSION: These findings suggest that donor alloantigen specific regulation by Tregs is one of multiple mechanisms that may contribute to the maintenance of liver graft survival in the absence of immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808539     DOI: 10.1016/j.transproceed.2004.12.259

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  18 in total

Review 1.  Immune profiling and cancer post transplantation.

Authors:  Christopher Martin Hope; Patrick Toby H Coates; Robert Peter Carroll
Journal:  World J Nephrol       Date:  2015-02-06

Review 2.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Paradigm shifts in the role of CD4+ T cells in keratoplasty.

Authors:  Khrishen Cunnusamy; Peter W Chen; Jerry Y Niederkorn
Journal:  Discov Med       Date:  2010-11       Impact factor: 2.970

Review 4.  T regulatory cells and transplantation tolerance.

Authors:  Vijay S Gorantla; Stefan Schneeberger; Gerald Brandacher; Robert Sucher; Dong Zhang; W P Andrew Lee; Xin Xiao Zheng
Journal:  Transplant Rev (Orlando)       Date:  2010-06-11       Impact factor: 3.943

Review 5.  Tolerance in clinical transplantation: progress, challenge or just a dream?

Authors:  Fred Fändrich
Journal:  Langenbecks Arch Surg       Date:  2011-03-17       Impact factor: 3.445

Review 6.  Environmental peer pressure: CD4+ T cell help in tolerance and transplantation.

Authors:  Dana Tedesco; Arash Grakoui
Journal:  Liver Transpl       Date:  2018-01       Impact factor: 5.799

7.  Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients.

Authors:  Udeme D Ekong; Xunrong Luo; Min Yu; Delli Wang; Stephen D Miller; Maurice R G O'Gorman
Journal:  Hum Immunol       Date:  2011-02-26       Impact factor: 2.850

Review 8.  T Follicular Regulatory Cells and Antibody Responses in Transplantation.

Authors:  Elizabeth F Wallin
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

Review 9.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

10.  Flt3L combined with rapamycin promotes cardiac allograft tolerance by inducing regulatory dendritic cells and allograft autophagy in mice.

Authors:  Ali Xiong; Lihua Duan; Jie Chen; Zhigang Fan; Fang Zheng; Zheng Tan; Feili Gong; Min Fang
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.